Daniel Trencher - Jan 10, 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
SVP Corporate Strategy
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Stock symbol
TDOC
Transactions as of
Jan 10, 2022
Transactions value $
-$118,900
Form type
4
Date filed
1/11/2022, 03:10 PM
Previous filing
Dec 13, 2021
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise $44.6K +2K +8.52% $22.30 25.5K Jan 10, 2022 Direct F1
transaction TDOC Common Stock Sale -$164K -2K -7.85% $81.75 23.5K Jan 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -2K -12.96% $0.00 13.4K Jan 10, 2022 Common Stock 2K $22.30 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 28, 2020.
F2 The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vested in 36 equal monthly installments thereafter.